Page 277 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology ANGPTL8 upregulation in CRC with liver metastasis

independent of insulin resistance in non-alcoholic fatty liver doi: 10.1371/journal.pone.0147367
disease patients. J Diabetes Investig. 2018;9(4):952-958.
46. Zheng J, Liu J, Hong BS, Ke W, Huang M, Li Y. Circulating
doi: 10.1111/jdi.12792 betatrophin/ANGPTL8 levels correlate with body fat
distribution in individuals with normal glucose tolerance
36. Xu F, Tian D, Shi X, Sun K, Chen Y. Analysis of the expression
and prognostic potential of a novel metabolic regulator but not those with glucose disorders. BMC Endocr Disord.
ANGPTL8/betatrophin in human cancers. Pathol Oncol Res. 2020;20:51.
2021;27:1609914. doi: 10.1186/s12902-020-0531-8
doi: 10.3389/pore.2021.1609914 47. Susanto H, Liu TY, Chen CC, Purnomo JD, Chen SF,
Wang CH. Increased serum levels of betatrophin in
37. Taherkhani F, Hosseini KM, Zebardast S, Chegini KG,
Gheibi N. Anti proliferative and apoptotic effects on pancreatic cancer-associated diabetes. Oncotarget.
pancreatic cancer cell lines indicate new roles for ANGPTL8 2106;7(27):42330-42339.
(Betatrophin). Genet Mol Biol. 2020;43(3):e20190196. doi: 10.18632/oncotarget.9815
doi: 10.1590/1678-4685-gmb-2019-0196 48. Carbone C, Piro G, Merz V, et al. Angiopoietin-like proteins
in angiogenesis, inflammation and cancer. Int J Mol Sci.
38. Monzavi N, Zargar SJ, Gheibi N, Azad M, Rahmani B.
Angiopoietin-like protein 8 (betatrophin) may inhibit 2018;19(2):431.
hepatocellular carcinoma through suppressing of the Wnt doi: 10.3390/ijms19020431
signaling pathway. Iran J Basic Med Sci. 2019;22(10):1166.
49. Susanto H, Firdaus SR, Sholeh M, et al. Moringa oleifera
doi: 10.22038/ijbms.2019.36612.8764 leaf powder – silver nanoparticles (MOLP-AgNPs)
efficiently inhibit metastasis and proliferative signaling
39. Gao Y, Yuan Y, Wen S, et al. Dual role of ANGPTL8 in
promoting tumor cell proliferation and immune escape in HT-29 human colorectal cancer cells. J Agric Food Res.
during hepatocarcinogenesis. Oncogenesis. 2023;12(1):26. 2024;16:101149.
doi: 10.1016/j.jafr.2024.101149
doi: 10.1038/s41389-023-00473-3
50. Abu-Farha M, Al-Khairi I, Cherian P, et al. Increased
40. Navaeian M, Ahmadpour-Yazdi H, Asadian S, Gheibi N. The
effect of ANGPTL8 protein on proliferation and apoptosis ANGPTL3, 4 and ANGPTL8/betatrophin expression levels
in HepG2 hepatocellular carcinoma cell line. Gene Reports. in obesity and T2D. Lipids Health Dis. 2016;15(1):181.
2021;25:101306. doi: 10.1186/s12944-016-0337-x
doi: 10.1016/j.genrep.2021.101306 51. Luo M, Peng D. ANGPTL8: An Important regulator
in metabolic disorders. Front Endocrinol (Lausanne).
41. Huot JR, Novinger LJ, Pin F, et al. Formation of colorectal
liver metastases induces musculoskeletal and metabolic 2018;9:169.
abnormalities consistent with exacerbated cachexia. JCI doi: 10.3389/fendo.2018.00169
Insight. 2020;5(9):e136687.
52. Guo Q, Cao S, Wang X. Betatrophin and insulin resistance.
doi: 10.1172/jci.insight.136687 Metabolites. 2022;12(10):925.
42. Shiono M, Huang K, Downey RJ, et al. An analysis of the doi: 10.3390/metabo12100925
relationship between metastases and cachexia in lung cancer 53. Maurer L, Brachs S, Decker AM, et al. Weight loss partially
patients. Cancer Med. 2016;5(9):2641-2648.
restores glucose-driven betatrophin response in humans.
doi: 10.1002/cam4.841 J Clin Endocrinol Metab. 2016;101(11):4014-4020.

43. Yi M, Chen RP, Yang R, Guo XF, Zhang JC, Chen H. doi: 10.1210/jc.2016-1788
Betatrophin acts as a diagnostic biomarker in type 2 diabetes 54. Susanto H, Taufiq A, Listyorini D, Handaya AY, Pertiwi MP.
mellitus and is negatively associated with HDL-cholesterol. Protein-based biomaterial marker in metabolic syndrome
Int J Endocrinol. 2015;2015:479157.
and colorectal cancer: A preliminary clinical study of
doi: 10.1155/2015/479157 betatrophin expression in Javanese Ethnic. IOP Conf Ser
Mater Sci Eng. 2019;515:012054.
44. Li S, Liu D, Li L, et al. Circulating betatrophin in patients
with type 2 diabetes: A meta-analysis. J Diabetes Res. doi: 10.1088/1757-899X/515/1/012054
2016;2016:6194750.
55. Susanto H. Betatrophin: The long-term exploration
doi: 10.1155/2016/6194750 of potential biomarker for metabolic syndrome and
cancer-related metabolic perturbation. AIP Conf Proc.
45. Abu-Farha M, Sriraman D, Cherian P, et al. Circulating
ANGPTL8/betatrophin is increased in obesity and reduced 2025;3186(1):020002.
after exercise training. PLOS One. 2016;11(1):e0147367. doi: 10.1063/5.0234671

Volume 9 Issue 2 (2025) 269 doi: 10.36922/EJMO025080034